Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Vinorelbine in Elderly Patients With Advanced NSCLC
NCT00165334Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jun 2005
- Primary completion
- Nov 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in non-small cell lung cancer (NSCLC), sponsored by Dana-Farber Cancer Institute. Started Jun 2005; status: completed.
02
Drugs
cetuximab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00165334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165334.